Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
47,970,593
-
Total 13F shares
-
38,451,731
-
Share change
-
+751,124
-
Total reported value
-
$836,163,596
-
Put/Call ratio
-
8.5%
-
Price per share
-
$21.75
-
Number of holders
-
164
-
Value change
-
+$17,223,500
-
Number of buys
-
79
-
Number of sells
-
56
Institutional Holders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) as of Q1 2023
As of 31 Mar 2023,
BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,451,731 shares.
The largest 10 holders included
Casdin Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, FRED ALGER MANAGEMENT, LLC, GENEVA CAPITAL MANAGEMENT LLC, Park West Asset Management LLC, STATE STREET CORP, PALISADE CAPITAL MANAGEMENT, LP, AMERIPRISE FINANCIAL INC, and JENNISON ASSOCIATES LLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.